Gen Pharma Trading Down News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Gen pharma trading down. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Gen Pharma Trading Down Today - Breaking & Trending Today

UroGen Pharma (NASDAQ:URGN) PT Lowered to $32.00 at Oppenheimer

UroGen Pharma (NASDAQ:URGN – Free Report) had its price target cut by Oppenheimer from $34.00 to $32.00 in a research report sent to investors on Tuesday, Benzinga reports. They currently have an outperform rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and set a $54.00 target price on shares of UroGen Pharma […] ....

Urogen Pharma , Mark Schoenberg , Urogen Pharma Ltd , Connor Clark Lunn Investment Management Ltd , China Universal Asset Management Co , Allspring Global Investments Holdings , Jump Financial , Securities Exchange Commission , Free Report , Gen Pharma Trading Down , Gen Pharma , Get Free Report , Exchange Commission , Global Investments Holdings , Universal Asset Management , Financial Markets , Connor Clark , Lunn Investment Management , Gen Pharma Ltd , Urogen Pharma Daily ,

UroGen Pharma's (URGN) "Buy" Rating Reiterated at HC Wainwright

UroGen Pharma's (URGN) "Buy" Rating Reiterated at HC Wainwright
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Urogen Pharma , Mark Schoenberg , Urogen Pharma Company Profile , Hermes Inc , Allspring Global Investments Holdings , Sg Americas Securities , Sierra Summit Advisors , China Universal Asset Management Co , Urogen Pharma Ltd , Free Report , Gen Pharma Trading Down , Gen Pharma , Get Free Report , Universal Asset Management , Global Investments Holdings , Gen Pharma Ltd , Urogen Pharma Daily ,

UroGen Pharma (URGN) Scheduled to Post Quarterly Earnings on Thursday

UroGen Pharma (NASDAQ:URGN – Get Free Report) will issue its quarterly earnings data before the market opens on Thursday, March 14th. Analysts expect the company to announce earnings of ($0.67) per share for the quarter. Parties that wish to register for the company’s conference call can do so using this link. UroGen Pharma Trading Down […] ....

Urogen Pharma , Mark Schoenberg , Group Plc , Urogen Pharma Ltd , Urogen Pharma Company Profile , Acadian Asset Management , Lazard Asset Management , Get Free Report , Gen Pharma Trading Down , Gen Pharma , General Counsel Jason Drew Smith , General Group Plc , Asset Management , Gen Pharma Ltd , Urogen Pharma Daily ,

Clal Insurance Enterprises Holdings Ltd Has $3.11 Million Stock Holdings in UroGen Pharma Ltd. (NASDAQ:URGN)

Clal Insurance Enterprises Holdings Ltd lessened its stake in UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 58.0% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 222,159 shares of the company’s stock after selling 307,229 shares during the quarter. Clal Insurance Enterprises Holdings […] ....

Urogen Pharma , Urogen Pharma Ltd , Millennium Management , Blackrock Inc , Stonepine Capital Management , Wells Fargo Company , Clal Insurance Enterprises Holdings Ltd , Urogen Pharma Company Profile , Free Report , Insurance Enterprises Holdings Ltd , Capital Management , Street Corp , Wells Fargo , Gen Pharma Trading Down , Gen Pharma , Get Free Report , Gen Pharma Ltd , Visit Holdingschannel , Urogen Pharma Daily , Nasdaq Urgn , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Stonepine Capital Management LLC Decreases Holdings in UroGen Pharma Ltd. (NASDAQ:URGN)

Stonepine Capital Management LLC decreased its position in UroGen Pharma Ltd. (NASDAQ:URGN – Free Report) by 36.1% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 448,508 shares of the company’s stock after selling 253,027 shares during the period. UroGen Pharma makes […] ....

Urogen Pharma , Northern Trust Corp , Urogen Pharma Ltd , Geode Capital Management , Exchange Commission , Wells Fargo Company , Stonepine Capital Management , Millennium Management , Securities Exchange Commission , Alphacentric Advisors , Free Report , Gen Pharma , Capital Management , Trust Corp , Centric Advisors , Wells Fargo , General Counsel Jason Drew Smith , Gen Pharma Trading Down , Gen Pharma Ltd , Visit Holdingschannel , Urogen Pharma Daily , Nasdaq Urgn , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,